Imagerie moléculaire et radio-ligands dans le cancer du sein

This publication has 48 references indexed in Scilit:

• Therapeutic impact of 18F-FDG PET/CT for initial staging in patients with clinical stage I and IIA, HER2-positive, or triple-negative breast cancer
  Breast Cancer Research and Treatment, 2024
• Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer
  European Journal of Nuclear Medicine and Molecular Imaging, 2024
• Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET
  Annals of Oncology, 2024
• Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
  Annals of Oncology, 2023
• ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
  Annals of Oncology, 2021
• Superiority of 68Ga-FAPI PET/CT scan in detecting additional lesions compared to 18FDG PET/CT scan in breast cancer
  Annals of Nuclear Medicine, 2021
• 68Ga-FAPI-04 PET/CT, a new step in breast cancer imaging: a comparative pilot study with the 18F-FDG PET/CT
  Annals of Nuclear Medicine, 2021
• The role of fibroblast activation protein in health and malignancy
  Cancer and Metastasis Reviews, 2020
• Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using 18F-FDG PET in luminal HER2-negative breast cancer
  European Journal of Nuclear Medicine and Molecular Imaging, 2013
• Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer
  European Journal of Nuclear Medicine and Molecular Imaging, 2010